Minnesota Patent of the Month – August 2024
4C Medical Technologies, Inc. has designed a single valve prosthetic heart meant to redefine how heart valve dysfunctions are treated. Unlike traditional solutions that replace the entire valve and physically interact with the native valve leaflets, this innovative device is designed to anchor within the left atrium without disturbing the natural valve structure.
The prosthetic valve is composed of an expandable anchoring structure and a unique single-leaflet design. This leaflet, positioned above the native valve annulus, operates as a one-way valve, preventing retrograde blood flow back into the left atrium while allowing forward flow into the left ventricle. The single leaflet’s simple yet effective mechanism ensures that blood flows smoothly, mimicking the natural function of the mitral valve with greater efficiency and less complexity.
One of the standout features of this device is its ability to progressively take over the function of the native mitral valve leaflets without replacing them entirely. This approach not only preserves some of the natural valve’s function but also minimizes the risk of complications associated with full valve replacement. The design is especially advantageous for patients whose native valve still retains some function but requires assistance to prevent backflow and manage blood flow effectively.
This prosthetic valve is also easier to deliver and position compared to traditional two-chamber solutions, which often involve complex anchoring systems and multiple components extending into the left ventricle. By focusing solely on the atrial chamber, 4C Medical’s design reduces procedural risks and potential trauma, offering a less invasive yet highly effective alternative for treating mitral valve regurgitation.
4C Medical Technologies’ prosthetic mitral valve device represents a significant advancement in heart valve treatment, providing a safer, more efficient solution for patients with dysfunctional mitral valves.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
